Advancing Neurophysiology & Cognition Translational Biomarkers to Drive Drug Development for Neuropsychiatric Disorders

Time: 9:40 am
day: Day One


• Addressing challenges in drug development for psychiatry requires establishing and validating translational biomarkers
• Biomarkers that capture modulation of neural function are key for pharmacodynamic assessments in disease-relevant circuits
• Objective digital measures can overcome the lack of precision in current clinical tools
• The ultimate goal is to move towards precision medicine in psychiatry by adopting biomarker sets that can contribute to patient selection for clinical trials

Download the event guide for full session details